Intellectual Property Cases
Cases 41 - 50 of 542
RSS Feed | View as table | Sort by filed date
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals U.S.A., Inc. We have downloadable decisions or orders for this case
as 1:2023cv00152
Plaintiff: Vanda Pharmaceuticals Inc.
Defendant: Teva Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al We have downloadable decisions or orders for this case
as 2:2023cv00018
Plaintiff: GW RESEARCH LIMITED
Defendant: TEVA PHARMACEUTICALS, INC., APOTEX INC., PADAGIS US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
VANDA PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS USA, INC. We have downloadable decisions or orders for this case
as 2:2022cv07528
Plaintiff: VANDA PHARMACEUTICALS INC.
Defendant: TEVA PHARMACEUTICALS USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
as 23-1247
Plaintiff / Appellant: VANDA PHARMACEUTICALS INC.
Defendant / Appellee: TEVA PHARMACEUTICALS USA, INC., APOTEX INC. and APOTEX CORP.
AbbVie Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2023cv00133
Plaintiff: AbbVie Inc.
Defendant: Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
as 22-1258
Plaintiff / Appellee: JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant / Appellant: TEVA PHARMACEUTICALS USA, INC., MYLAN LABORATORIES LIMITED and MYLAN LABORATORIES LTD.
Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al We have downloadable decisions or orders for this case
as 1:2022cv01461
Counter Defendant: Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant: Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Teva Pharmaceutical Industries Ltd. et al
as 1:2022cv01462
Counter Defendant: Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant: Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?